Revisiting the Term “Compassionate Use” and Leadership of the World Health Organization in Resolving Confusion in the Age of COVID-19 and Beyond | JMA Journal
Summary of 'compassionate use' regulations in ten European countries | Download Table
NPU Definition: Named Patient Use | Abbreviation Finder
Compassionate Use and other Managed Access Concepts - GMP Journal
Named patient use (NPU) program for afatinib in advanced/metastatic... | Download Scientific Diagram
Egetis receives approval in Turkey for compassionate use of Emcitate® for MCT8 deficiency
NAMED PATIENT PROGRAMMES
Named Patient Program – Trackcircle
Mycophenolate mofetil bulk exporter Cellmune 500mg Tablet named patient supply
Intermediate-Size Patient Populations INDs: What Are They, When Should They Be Used, and Who May Apply for Them?” Richard Klein, Former Director, FDA. - ppt download
EMD Serono Position Statement on Early Access to Experimental Medicine
The Impact of Off-Label, Compassionate and Unlicensed Use on Health Care Laws in preselected Countries | Semantic Scholar
Special licence procedure in Finland
Compassionate use programs and the European regulatory system Filip Josephson M.D., Ph.D. Clinical Assessor. - ppt download
Named patient program (NPP) service by Globe Medical
Comparison of EAPs in the US to CUP and NPP in the EU | Download Table
Compassionate Use and other Managed Access Concepts - GMP Journal
Frontiers | Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
Name Patient Program - World Pharma Network
Compassionate Use and other Managed Access Concepts - GMP Journal
Named Patient Import Service - TOLL FREE: 1800-889-1064
Compassionate Use and other Managed Access concepts – Requirement Landscape across Europe from
Named patient program - ICG Farma
Named patient use (NPU) program for afatinib in advanced/metastatic... | Download Scientific Diagram
